ArticleJournal of the American Chemical Society2018

Anti-EGFR Affibodies with Site-Specific Photo-Cross-Linker Incorporation Show Both Directed Target-Specific Photoconjugation and Increased Retention in Tumors.

Michael Brasino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.